148 related articles for article (PubMed ID: 6833151)
1. Rapid uptake by cultured tumor cells and intracellular behavior of 4'-O-tetrahydropyranyladriamycin.
Kunimoto S; Miura K; Takahashi Y; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1983 Mar; 36(3):312-7. PubMed ID: 6833151
[TBL] [Abstract][Full Text] [Related]
2. Cellular pharmacology of N,N-dimethyl daunorubicin and N,N-dimethyl adriamycin.
Egorin MJ; Clawson RE; Ross LA; Bachur NR
Cancer Res; 1980 Jun; 40(6):1928-33. PubMed ID: 7371027
[No Abstract] [Full Text] [Related]
3. Correlation between nuclear action of anthracycline anticancer agents and their binding affinity to the proteasome.
Kiyomiya K; Satoh J; Horie H; Kurebe M; Nakagawa H; Matsuo S
Int J Oncol; 2002 Nov; 21(5):1081-5. PubMed ID: 12370758
[TBL] [Abstract][Full Text] [Related]
4. Studies on aclacinomycin A resistance in mouse lymphoblastoma.
Nishimura T; Suzuki H; Muto K; Tanaka Y; Tanaka N
J Antibiot (Tokyo); 1980 Jul; 33(7):737-43. PubMed ID: 6931828
[TBL] [Abstract][Full Text] [Related]
5. Uptake and binding of 3'-(3-cyano-4-morpholinyl)-3'-deaminoadriamycin and 3'-(4-morpholinyl)-3'-deaminoadriamycin in L5178Y lymphoblasts in vitro.
Begleiter A; Jesson MI; Johnston JB
Cancer Commun; 1990; 2(1):7-12. PubMed ID: 2196074
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of action of 2-crotonyloxymethyl-4,5,6-trihydroxycyclohex-2-enone, a SH inhibitory antitumor antibiotic, and its effect on drug-resistant neoplastic cells.
Sugimoto Y; Suzuki H; Yamaki H; Nishimura T; Tanaka N
J Antibiot (Tokyo); 1982 Sep; 35(9):1222-30. PubMed ID: 7142023
[TBL] [Abstract][Full Text] [Related]
7. Differential cell-cycle-dependent inhibition of DNA synthesis by hydroxyurea and cytosine arabinoside in cultured L5178Y mouse lymphoma cells.
Malec J; Kornacka L; Sawecka J
Arch Immunol Ther Exp (Warsz); 1979; 27(4):539-45. PubMed ID: 518260
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activities of (2"R)-4'-O-tetrahydropyranyl-adriamycin (THP) and its combination with other antitumor agents on murine tumors.
Matsushita Y; Kumagai H; Yoshimoto A; Tone H; Ishikura T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1985 Oct; 38(10):1408-19. PubMed ID: 4066493
[TBL] [Abstract][Full Text] [Related]
9. Experimental studies of new anthracyclines: aclacinomycin, THP-adriamycin and ditrisarubicins.
Umezawa K; Kunimoto S; Takeuchi T
Biomed Pharmacother; 1987; 41(5):206-13. PubMed ID: 2444279
[TBL] [Abstract][Full Text] [Related]
10. Relationship between the intracellular level and growth inhibition of a new anthracycline 4'O-tetrahydropyranyl-Adriamycin in Friend leukemia cell variants.
Munck JN; Fourcade A; Bennoun M; Tapiero H
Leuk Res; 1985; 9(2):289-96. PubMed ID: 3990336
[TBL] [Abstract][Full Text] [Related]
11. Cellular pharmocodynamics of several anthrocycline antibiotics.
Bachur NR; Steele M; Meriwether WD; Hildebrand RC
J Med Chem; 1976 May; 19(5):651-4. PubMed ID: 1271407
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and disposition of 4'-O-tetrahydropyranyladriamycin in mice by HPLC analysis.
Iguchi H; Tone H; Ishikura T; Takeuchi T; Umezawa H
Cancer Chemother Pharmacol; 1985; 15(2):132-40. PubMed ID: 4017162
[TBL] [Abstract][Full Text] [Related]
13. 4'-O-tetrahydropyranyladriamycin as a potential new antitumor agent.
Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y
Cancer Res; 1982 Apr; 42(4):1462-7. PubMed ID: 7060020
[TBL] [Abstract][Full Text] [Related]
14. Arabinosyl nucleosides. XXXII. Mechanism of inhibition of L5178y mouse lymphoma cells by 9-beta-D-arabinofuranosylguanine.
Müller WE; Geurtsen W; Beyer R; Schuster DK; Zahn RK; Arendes J
Chem Biol Interact; 1981 Mar; 34(3):301-13. PubMed ID: 7460088
[TBL] [Abstract][Full Text] [Related]
15. Cellular uptake and efflux and cytostatic activity of 4'-O-tetrahydropyranyladriamycin in adriamycin-sensitive and resistant tumor cell lines.
Kunimoto S; Miura K; Umezawa K; Xu CZ; Masuda T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1984 Dec; 37(12):1697-702. PubMed ID: 6526737
[TBL] [Abstract][Full Text] [Related]
16. Poly (ADP-ribose) metabolism in alkylated mouse L5178Y cells.
Boyle JM
Carcinogenesis; 1985 Jul; 6(7):1005-9. PubMed ID: 2990753
[TBL] [Abstract][Full Text] [Related]
17. Action of misonidazole on L5178Y-R and L5178Y-S cells. I. Comparison with antimycin A and potassium cyanide under aerobic conditions.
Budzicka E; Niepokojczycka E; Szumiel I
Neoplasma; 1981; 28(4):423-33. PubMed ID: 7290266
[TBL] [Abstract][Full Text] [Related]
18. Inhibition and resumption of replicon initiation in X-irradiated mouse L5178Y cells.
Shinohara K; Watanabe I
Radiat Environ Biophys; 1983; 21(3):163-73. PubMed ID: 6844548
[TBL] [Abstract][Full Text] [Related]
19. Cellular pharmacology of detorubicin and doxorubicin in L1210 cells.
Zenebergh A; Baurain R; Trouet A
Eur J Cancer Clin Oncol; 1984 Jan; 20(1):115-21. PubMed ID: 6537910
[TBL] [Abstract][Full Text] [Related]
20. Antitumor spectrum of a new anthracycline, (2"R)-4'-O-tetrahydropyranyladriamycin, and effect on the cellular immune response in mice.
Hisamatsu T; Suzuki K; Sakakibara S; Komuro K; Nagasawa M; Takeuchi T; Umezawa H
Jpn J Cancer Res; 1985 Oct; 76(10):1008-20. PubMed ID: 3935619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
